Colombia To Make HIV Treatment More Accessible Through Compulsory Licensing
Eurasia Review
After years of mobilization and advocacy, Dolutegravir—a first-line drug in HIV treatment—will be more widely available in..
After years of mobilization and advocacy, Dolutegravir—a first-line drug in HIV treatment—will be more widely available in..
Pfizer Inc. (NYSE: PFE) has announced its financial outcomes for the first quarter of 2024, displaying strong performance in its..